Belumosudil achieves clinical response in chronic graft-<i>versus</i>host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial
Authors
Alaa Ali
Kathy Marshall
Yu Yao (ORCID: https://orcid.org/0009-0002-3343-3235)
Ran Ji (ORCID: https://orcid.org/0009-0004-7322-4352)
Belumosudil achieves clinical response in chronic graft-versushost disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial
Alaa Ali, Kathy Marshall, Yu Yao, Ran Ji et al.
Journal
Haematologica
Topics
Hematopoietic Stem Cell Transplantation
article
Belumosudil achieves clinical response in chronic graft-versushost disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial
Alaa Ali, Kathy Marshall, Yu Yao, Ran Ji, Lauren Rota, Zachariah DeFilipp
article en
Abstract
No abstract available for this paper.
Publication Tag
Haematologica
Institutions
Morristown Medical Center (US), Moffitt Cancer Center (US), Sanofi (United States) (US), C3I (United States) (US), Harvard Stem Cell Institute (US)